Archie from United Kingdom

Registered at the short selling broker NS Broker, 4 minutes ago.

» Try NS Broker you too
54.6% of retail CFD accounts lose money.
Don't show again

Avenue Therapeutics Inc (ATXI) shares information

Avenue Therapeutics Inc

24h Change

-3.43 %


Live rate: Market closed

Stock data per Friday 25 Nov, 2022

-0.05 (-3.43%)
US Market is closed

Live Stock price in graph for Avenue Therapeutics Inc (ATXI)

  • Latest Volume

    175,924 (-34.37 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    1.51 USD

  • Today low

    1.36 USD

  • 52 week high

    26.85 USD

  • 52 week low

    1.36 USD

  • YTD Change


Quick links


Latest news about Avenue Therapeutics Inc

Below you can find the most recent news posts about Avenue Therapeutics Inc, primarily from US and UK based news sources.

Is Avenue Therapeutics Inc. (NASDAQ: ATXI) Still A Buy After sinking -4.79% Last Week?

Thursday, 17 November 2022, 16:00:00
During the last session, Avenue Therapeutics Inc. (NASDAQ:ATXI)’s traded shares were 1.31 million, with the beta value of the company hitting -0.56. At the end of the trading day, the stock’s price was $1.79, reflecting an intraday gain of 7.83% or $0.13. The 52-week high for the ATXI share is $26.85, that puts it down … Is Avenue Therapeutics Inc. (NASDAQ: ATXI) Still A Buy After sinking -4.79% Last Week? Read More »
— Marketing Sentinel

Avenue Therapeutics GAAP EPS of -$0.45

Tuesday, 15 November 2022, 14:30:10
Avenue Therapeutics press release (ATXI): Q3 GAAP EPS of -$0.45.As of September 30, 2022, Avenue’s cash and cash equivalents totaled $0.2M, compared to $3.8M at December 31, 2021.
— Seeking Alpha

Have you been able to find a good deal on Avenue Therapeutics Inc.’s shares?

Monday, 7 November 2022, 17:48:00
The share price of Avenue Therapeutics Inc. (NASDAQ:ATXI) fell to $1.78 per share on Friday from $1.99. While Avenue Therapeutics Inc. has underperformed by -10.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ATXI fell by -92.67%, with highs and lows ranging from $27.75 to $1.98, […]
— US Post News

US Stocks Open Lower; Dow Drops Over 100 Points

Friday, 14 October 2022, 16:59:57
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.37% to 29,927.92 while the NASDAQ fell 1.44% to 10,495.56. The S&P 500 also fell, dropping, 0.98% to 3,634.00. Also check this: Market Volatility Declines Following US Inflation Data Leading and Lagging Sectors Health care shares fell by just 0.4% on Friday. Leading the sector was strength from Reata Pharmaceuticals, Inc. (NASDAQ: RETA ) and Valneva SE (NASDAQ: VALN ). In trading on Friday, energy shares dipped by 2.9%. Top Headline US retail trade came in unchanged for September, missing market estimates for a 0.2% rise. Equities Trading UP Gravitas Education Holdings, Inc. (NASDAQ: GEHI ) shares shot up 78% to $26.65. Shares of Avenue Therapeutics, Inc. (NASDAQ: ATXI ) got a boost, shooting 43% to $3.4806. Avenue Therapeutics recently priced a roughly 3.6 million unit offering at $3.30 per unit. IMARA Inc. (NASDAQ: IMRA ) shares were also up, gaining 35% to $3.47 after the …
— Benzinga

Avenue Therapeutics shares slide on pricing $12M securities offering (NASDAQ:ATXI)

Friday, 7 October 2022, 09:55:09
Avenue Therapeutics (ATXI) is down 10.8% after-hours after the firm has priced its underwritten public offering of 3,636,365 common and pre-funded units.Each common unit consists of…
— Seeking Alpha

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have ATXI available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.